The Insulin Dosage Market in Lithuania showed fluctuating trends over the past decade, reaching a value of $34.051 million in 2023. Following an initial growth period, the market experienced sporadic declines with a notable dip in 2018 and recent contractions in 2022 and 2023. Year-on-year changes indicate volatility, with significant drops in certain years impacting the overall five-year CAGR, resulting in a decline of 2.71%. The market's trajectory reflects adjustments in demand or policy influences.
Future trends to watch for include shifts in healthcare policies, the introduction of new insulin forms, and patient demographic changes, potentially impacting market dynamics and leading to recovery or further declines.
How does Lithuania rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 22 | 22 Morocco | 42,235,000 | 2023 | +1.18% | +1.18% | View data |
| 23 | 23 Slovenia | 36,304,000 | 2023 | +0.66% | -1.13% | View data |
| 24 | 24 Lithuania | 34,051,000 | 2023 | -2.22% | -2.71% | |
